Answers are grounded in this paper and cite their sources.
INTRODUCTION: In Hong Kong, tuberculin skin test (TST) with a 15 mm cut-off was used at 0 and 3 months for contact screening, but half of future tuberculosis cases might be missed. Follow-on interferon-gamma release assay (IGRA) was added for those with tuberculin reaction of 5-14 mm in a pilot programme. METHODS: This was a prospective cohort study. All household contacts of smear-positive tuberculosis aged 12-64 registered in Hong Kong Tuberculosis and Chest Service from 1 July 2018 to 30 June 2022 were prospectively tracked through medical records and the territory-wide tuberculosis notification registry for active tuberculosis till 31 December 2022. RESULTS: Among untreated contacts with tuberculin reaction of 5-14 mm in either the initial test or second test at 3 months, the tuberculosis rate among those with a follow-on reactive IGRA was significantly higher than those with a non-reactive IGRA (12.44 vs 0.75 per 1000 person-years, relative risk: 16.52, p=0.003). After adjustment for the efficacy of preventive treatment among all treated cases, the estimated proportions of tuberculosis cases captured by the pilot programme criterion of TST≥15 mm/TST 5-14 mm and IGRA reactive/TST conversion were similar to those captured by TST cut-offs of 5 mm or 10 mm, despite consistently lower positive rates. With an overall test-positive rate of 54.5%, the pilot programme captured 95.8% of estimated future tuberculosis cases at a relative risk between test-positive and test-negative cases of 19. CONCLUSION: Combining TST with follow-on IGRA for those with tuberculin reaction of 5-14 mm markedly improves screening of household contacts in an intermediate burden setting.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: